| Effectiveness of nirmatrelvir/ritonavir in children and adolescents aged 12–17 years following SARS-CoV-2 Omicron infection: A target trial emulation CKH Wong, KTK Lau, ICH Au, SHS Chan, EHY Lau, BJ Cowling, ... Nature Communications 15 (1), 4917, 2024 | | 2024 |
| Joint analysis of vaccination effectiveness and antiviral drug effectiveness for COVID-19: a causal inference approach YYH Cheung, EHY Lau, G Yin, Y Lin, J Jiang, BJ Cowling, KF Lam International Journal of Infectious Diseases 143, 107012, 2024 | | 2024 |
| The Impact of Medical Resources and Oral Antiviral Drugs on SARS-CoV-2 Mortality—Hong Kong SAR, China, 2022 Z Zeng, J Liang, Z Lin, W Guan, W He, Q Li, L Liang, W Pan, Z Liu, G Lu, ... China CDC Weekly 6 (21), 469, 2024 | | 2024 |
| Global Seasonal Activities of Respiratory Syncytial Virus Before the Coronavirus Disease 2019 Pandemic: A Systematic Review S Shan, W Zhang, H Gao, PY Huang, Z Du, Y Bai, YC Lau, D Chen, ... Open Forum Infectious Diseases 11 (5), ofae238, 2024 | 1 | 2024 |
| A retrospective cohort study of Paxlovid efficacy depending on treatment time in hospitalized COVID-19 patients Z Du, L Wang, Y Bai, Y Liu, EHY Lau, AP Galvani, RM Krug, BJ Cowling, ... Elife 13, e89801, 2024 | | 2024 |
| Association of COVID-19 vaccination with duration of hospitalization in older adults in Hong Kong D Chen, BJ Cowling, KEC Ainslie, Y Lin, JY Wong, EHY Lau, P Wu, ... Vaccine 42 (9), 2385-2393, 2024 | 1 | 2024 |
| Comparison of bivalent and monovalent mRNA vaccine boosters CKH Wong, KTK Lau, ICH Au, EHY Lau, BJ Cowling Clinical Infectious Diseases 78 (3), 633-636, 2024 | | 2024 |
| Effectiveness of mRNA BNT162b2 and inactivated CoronaVac vaccines against severe COVID-19 outcomes among non-hospitalised children aged 1-3 years with SARS-CoV-2 Omicron infection CKH Wong, KTK Lau, ICH Au, EHY Lau, BJ Cowling International Journal of Antimicrobial Agents 63 (3), 107094, 2024 | | 2024 |
| Estimation of the Time-Varying Effective Reproductive Number of COVID-19 Based on Multivariate Time Series of Severe Health Outcomes BR Young, F Ho, Y Lin, EHY Lau, BJ Cowling, P Wu, TK Tsang The Journal of Infectious Diseases 229 (2), 502-506, 2024 | | 2024 |
| Early sepsis care with the National Early Warning Score 2-guided Sepsis Hour-1 Bundle in the emergency department: hybrid type 1 effectiveness-implementation pilot stepped … RPK Lam, KKC Hung, CT Lui, WS Kwok, WWT Lam, EHY Lau, S Sridhar, ... BMJ open 14 (2), e080676, 2024 | | 2024 |
| Public Health Impact of Paxlovid as Treatment for COVID-19, United States Y Bai, Z Du, L Wang, EHY Lau, ICH Fung, P Holme, BJ Cowling, ... Emerging Infectious Diseases 30 (2), 262, 2024 | 3 | 2024 |
| Comparison of control and transmission of COVID-19 across epidemic waves in Hong Kong: an observational study B Yang, Y Lin, W Xiong, C Liu, H Gao, F Ho, J Zhou, R Zhang, JY Wong, ... The Lancet Regional Health–Western Pacific 43, 2024 | 16 | 2024 |
| Immuno-persistence after the 4th and 5th dose of inactivated polio vaccines in school-aged children K Leung, CWK Pang, THK Lo, J Vargas-Zambrano, C Petit, TTY Lam, ... | | 2024 |
| Effective real-time transmission estimations incorporating population viral load distributions amid SARS-CoV-2 variants and pre-existing immunity Y Meng, Y Lin, W Xiong, EHY Lau, F Ho, JY Wong, P Wu, TK Tsang, ... medRxiv, 2024.05. 27.24307968, 2024 | | 2024 |
| Decreased risk of non-influenza respiratory infection after influenza B virus infection in children TK Tsang, RQR Du, VJ Fang, EHY Lau, KH Chan, DKW Chu, DKM Ip, ... Epidemiology & Infection 152, e60, 2024 | | 2024 |
| Effectiveness of Vaccines and Antiviral Drugs in Preventing Severe and Fatal COVID-19, Hong Kong YYH Cheung, EHY Lau, G Yin, Y Lin, BJ Cowling, KF Lam Emerging Infectious Diseases 30 (1), 70, 2024 | 2 | 2024 |
| Nirmatrelvir/ritonavir use in pregnant women with SARS-CoV-2 Omicron infection: a target trial emulation CKH Wong, KTK Lau, MSH Chung, ICH Au, KW Cheung, EHY Lau, ... Nature Medicine 30 (1), 112-116, 2024 | 5 | 2024 |
| Author Correction: Real-world COVID-19 vaccine effectiveness against the Omicron BA. 2 variant in a SARS-CoV-2 infection-naive population JJ Lau, SMS Cheng, K Leung, CK Lee, A Hachim, LCH Tsang, KWH Yam, ... Nature medicine 30 (1), 305-305, 2024 | | 2024 |
| Nowcasting and Forecasting Seasonal Influenza Epidemics—China, 2022–2023 Z Du, Z Shao, X Zhang, R Chen, T Chen, Y Bai, L Wang, EHY Lau, ... China CDC Weekly 5 (49), 1100, 2023 | 1 | 2023 |
| Risk of acute liver injury following the nirmatrelvir/ritonavir use CKH Wong, LY Mak, ICH Au, WY Cheng, CH So, KTK Lau, EHY Lau, ... Liver International 43 (12), 2657-2667, 2023 | 2 | 2023 |
